Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 10Lymphoid 10Dermatologic 7Sarcoma 5Plasma cell 4Myeloid 4Other neoplasm 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 18Leukemia 17Myelodysplastic Syndromes 16Leukemia, Myelomonocytic, Chronic 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Myeloid, Acute 11Congenital Abnormalities 10Myeloproliferative Disorders 8Blast Crisis 8Myelodysplastic-Myeloproliferative Diseases 7Lymphoma 7Leukemia, Myeloid, Accelerated Phase 7Anemia, Refractory 7Primary Myelofibrosis 6Lymphoma, Non-Hodgkin 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Leukemia, Lymphocytic, Chronic, B-Cell 6Polycythemia Vera 5Multiple Myeloma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Burkitt Lymphoma 5Thrombocytopenia 4Thrombocythemia, Essential 4Neoplasms, Plasma Cell 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4

Interventions

Mycophenolic Acid 7fludarabine phosphate 5Tacrolimus 5Cyclosporine 5Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Whole-Body Irradiation 3Therapeutics 3Methotrexate 3Melphalan 3Cord Blood Stem Cell Transplantation 3Busulfan 3merphos 2Methylprednisolone 2Filgrastim 2Epoetin Alfa 2Darbepoetin alfa 2Antilymphocyte Serum 2obinutuzumab 1laromustine 1fludarabine 1ferrous sulfate 1ferric gluconate 1Vorinostat 1Valganciclovir 1Transplantation 1Tetradecanoylphorbol Acetate 1Sucrose 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × Etoposide × Classical hematology × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡